Clinical Trial Update: FOLFIRI and Sunitinib in Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating FOLFIRI with Sunitinib in metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Liver Metastases

Drugs mentioned

• FOLFIRI (irinotecan, leucovorin, 5-fluorouracil)
• Sunitinib (sunitinib)

Snippet

Sponsor: Central European Society for Anticancer Drug Research | Conditions: Metastatic Colorectal Cancer, Liver Metastases | Phase 2 | Status: COMPLETED